Viewing Study NCT01588769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-06-04 @ 4:46 AM
Study NCT ID: NCT01588769
Status: COMPLETED
Last Update Posted: 2016-06-06
First Post: 2012-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
Sponsor: CytoVac A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma Multiforme View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioblastoma Multiforme View
None Brain cancer View
None Immunotherapy View
None Cell based therapy View
None Autologous cell based therapy View
None Adoptive immunotherapy View
None Cytotoxic T cells View
None Natural Killer cells View